Patents Assigned to University of Texas Board of Regents
-
GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF
Publication number: 20130030051Abstract: The present invention provides compositions and methods based on genetic polymorphisms that are associated with cardiovascular diseases, particularly coronary heart disease (especially myocardial infarction) or hypertension. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.Type: ApplicationFiled: June 1, 2012Publication date: January 31, 2013Applicants: UNIVERSITY OF TEXAS BOARD OF REGENTS, CELERA CORPORATIONInventors: Dov SHIFFMAN, James J. DEVLIN, Judy Z. LOUIE, Eric BOERWINKLE -
Patent number: 7897797Abstract: Azidoaryl-substituted cyclooctene monomers and synthesized and used in the preparation of various copolymers. Among these copolymers are those prepared from ring-opening metathesis polymerization of cyclooctene, polyethylene glycol-substituted cyclooctene, and azidoaryl-substituted cyclooctene. These copolymers are useful in the formation of crosslinked films that reduce fouling of water purification membranes.Type: GrantFiled: April 16, 2010Date of Patent: March 1, 2011Assignees: The University of Massachusetts, The University of Texas Board of RegentsInventors: Todd Shannon Emrick, Kurt Breitenkamp
-
GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF
Publication number: 20100035983Abstract: The present invention provides compositions and methods based on genetic polymorphisms that are associated with cardiovascular diseases, particularly coronary heart disease (especially myocardial infarction) or hypertension. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.Type: ApplicationFiled: July 9, 2009Publication date: February 11, 2010Applicants: CELERA CORPORATION, UNIVERSITY OF TEXAS BOARD OF REGENTSInventors: Dov SHIFFMAN, James J. DEVLIN, Judy Z. LOUIE, Eric BOERWINKLE -
Patent number: 7592161Abstract: The present invention provides a system and methods for analyzing the function of nucleotide integrases and modified group II introns. The system comprises a donor plasmid comprising a wild-type or modified group II intron, a recipient plasmid comprising a DNA recognition site and a promoterless reporter gene downstream of the DNA target site, and a host cell. The method comprises the steps of transforming a host cell with the donor and recipient plasmids, assaying for expression of the reporter gene, isolating plasmid DNA from the cotransformed cells, and analyzing the plasmid DNA to confirm that the group II intron has been inserted into the target sequence. The present invention also provides a method for simultaneously analyzing the activity of two or more modified nucleotide integrases. The present invention also relates to methods of preparing a library of donor plasmids containing a plurality of diverse modified group II intron DNA sequences.Type: GrantFiled: October 22, 2002Date of Patent: September 22, 2009Assignees: The Ohio State University Research Foundation, The University of Texas Board of Regents of the University of Texas SystemInventors: Alan M. Lambowitz, Huatao Guo, Michael Karberg
-
Publication number: 20090025246Abstract: An apparatus to control displacement of a body spaced-apart from a surface includes a flexure system having a first flexure member defining a first axis of rotation and a second flexure member defining a second axis of rotation. A body is coupled to the flexure system to move about a plurality of axes. An actuation system is coupled to the flexure system to selectively constrain movement of the body along a subset of the plurality of axes.Type: ApplicationFiled: October 3, 2008Publication date: January 29, 2009Applicant: THE UNIVERSITY OF TEXAS BOARD OF REGENTSInventors: Byung-Jin Choi, Sidlgata V. Sreenivasan, Stephen C. Johnson
-
Publication number: 20080199816Abstract: Disclosed herein is an automatic fluid dispensing method and system for dispensing fluid on the surface of a plate-like material, or substrate, including a semiconductor wafer for imprint lithography processes. The dispensing method uses fluid dispenser and a substrate stage that may generate relative lateral motions between a fluid dispenser tip a substrate. Also described herein are methods and devices for creating a planar surface on a substrate using a substantially unpatterned planar template.Type: ApplicationFiled: July 9, 2007Publication date: August 21, 2008Applicant: THE UNIVERSITY OF TEXAS BOARD OF REGENTSInventors: Byung J. Choi, S. V. Sreenivasan, C. Grant Willson, Matthew Colburn, Todd Bailey, John Ekerdt
-
Patent number: 6608896Abstract: Computationally efficient DTMF detection methods and apparatus are presented that meet all of the ITU recommendations using the modified non-uniform DFT. The system of the present invention employs a high band filter block and two low band filter blocks to detect power at the 8 DTMF tones. The frame length of the high band filter blocks is one half the length of the low band filter blocks. The frame lengths are chosen to meet the ITU frequency selectivity requirements for all DTMF frequencies. The frames of the two low band filter blocks are staggered to produce outputs alternately, and are aligned with respect to the frame of the high band filter block to produce low band filter block outputs that coincided with the high band filter block outputs without the need for signal buffering. A system of power level tests are employed in conjunction with a system of timing tests to ensure that all ITU timing and frequency constraints are met.Type: GrantFiled: December 7, 2001Date of Patent: August 19, 2003Assignee: University of Texas Board of RegentsInventors: Matthew D. Felder, James C. Mason, Brian L. Evans
-
Publication number: 20030082640Abstract: The invention provides methods and compositions for inducing and detecting signal transduction through LDL receptors, including specifically detecting a stress that alters a functional interaction of a low density lipoprotein (LDL) receptor binding polypeptide with an LDL receptor interaction domain, by (a) introducing a predetermined stress into a system which provides a physical interaction of an LDL receptor binding polypeptide with an LDL receptor intracellular binding polypeptide interaction domain, whereby the system provides a stress-biased interaction of the binding polypeptide and the interaction domain, wherein the absence of the stress, the system provides a unbiased interaction of the binding polypeptide and the interaction domain; and (b) detecting the stress-biased interaction of the binding polypeptide and the interaction domain, wherein the binding polypeptide is selected from SEMCAP-1, JIP-1, PSD-95, JIP-2, Talin, OMP25, CAPON, PIP4,5 kinase, Na channel brain 3, Mint1, ICAP-1 and APC subunit1Type: ApplicationFiled: August 1, 2002Publication date: May 1, 2003Applicant: The University of Texas Board of RegentsInventors: Joachim Herz, Michael Gotthardt
-
Patent number: 5672490Abstract: The present invention provides various novel covalently modified sapphyrin derivatives and conjugates; polymers including sapphyrin or derivatives thereof; and chromatographic supports including sapphyrins and other expanded porphyrins and derivatives thereof. Disclosed are water soluble sapphyrins, including polyhydroxysapphyrins and sapphyrin-sugar derivatives; sapphyrin-metal chelating conjugates; sapphyrin nucleobase conjugates; oligosapphyrins and polysapphyrins, including sapphyrin dimers, trimers, oligomers and higher polymers; and polymer supported expanded porphyrin compositions, including advantageous rubyrin- and sapphyrin-based chromatography columns and electrophoretic supports. Sapphyrin oligomers and polymers and polymer supported expanded porphyrins, such as, e.g.Type: GrantFiled: June 2, 1995Date of Patent: September 30, 1997Assignee: The University of Texas Board of RegentsInventors: Jonathan L. Sessler, Brent L. Iverson, Vladimir Kral, Kevin Shreder, Hiroyuki Furuta, Richard E. Thomas
-
Patent number: 5637456Abstract: The present invention relates generally to the area of quality control for recombinant agents to be used in gene therapy. Specifically, the invention concerns an assay used to identify the percentage of defective or therapeutically inactive vector in a vector stock.Type: GrantFiled: February 17, 1995Date of Patent: June 10, 1997Assignees: The University of Texas, Board of Regents, Rhone Poulenc RorerInventors: Jack A. Roth, Wei Wei Zhang, Bruno Tocque, Laurent Bracco
-
Patent number: 5281694Abstract: The molecular cloning and nucleotide sequence of the complete structural gene encoding Mycoplasma pneumoniae P1 cytadhesin and the amino acid sequence of the protein is described. The present invention provides recombinant DNA clones encoding the complete P1 protein as well as clones expressing P1 polypeptides with cytadhesin epitopes. The substantially purified nucleic acid molecules, recombinant vectors, recombinant cells, and recombinant polypeptides of the present invention are useful as hybridization probes and immunodiagnostic reagents and may be used to prepare anti-mycoplasmal vaccines.Type: GrantFiled: March 5, 1991Date of Patent: January 25, 1994Assignee: The University of Texas Board of RegentsInventors: Joel B. Baseman, C. J. Su, S. F. Dallo
-
Patent number: 5026636Abstract: The molecular cloning and nucleotide sequence of the complete structural gene encoding Mycoplasma pneumoniae P1 cytadhesin and the amino acid sequence of the P1 protein is described. The present invention provides recombinant DNA clones encoding the complete P1 protein as well as clones expressing P1 polypeptides with cytadhesin epitopes. The substantially purified nucleic acid molecular recombinant vectors, recombinant cells, and recombinant polypeptides of the present invention are useful as hybridization probes and immunodiagnostic reagents and may be used to prepare anti-mycoplasmal vaccines.Type: GrantFiled: November 10, 1987Date of Patent: June 25, 1991Assignee: The University of Texas Board of RegentsInventors: Joel B. Baseman, C. J. Su, S. F. Dallo
-
Patent number: 4950597Abstract: The present invention involves a process for screening for and isolating spontaneously occurring or induced cellulose II-producing microorganisms. The process comprises a series of steps in various embodiments. Initially, cellulose-producing microorganisms from a first culture are plated out on a nutrient agar plate. The nutrient agar plate is then incubated to facilitate formation of colonies from single microorganisms. Samples of liquid nutrient medium are then inoculated with microorganisms from colonies having a smooth configuration, as compared to the usual rough colony configuration. The inoculated samples are then aerobically incubated to facilitate microorganism proliferation and pellicle formation. From these incubated samples are selected microorganisms, which, after a cultivation period, have proliferated but not formed a pellicle. Said selected microorganisms produce cellulose II instead of the cellulose I produced by pellicle-forming organisms.Type: GrantFiled: May 25, 1988Date of Patent: August 21, 1990Assignee: The University of Texas Board of RegentsInventors: Inder M. Saxena, Eric M. Roberts, R. Malcolm Brown, Jr.